Log In
BCIQ
Print this Print this
 

ROR gamma ligands

  Manage Alerts
Collapse Summary General Information
Company Orphagen Pharmaceuticals Inc.
DescriptionSmall molecule inhibitors of ROR-gamma
Molecular Target RAR-related orphan receptor (ROR)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentDiscovery
Standard Indication Autoimmune (unspecified)
Indication DetailsTreat autoimmune diseases
Regulatory Designation
PartnerJapan Tobacco Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today